Progesterone receptor membrane component 1 is phosphorylated upon progestin treatment in breast cancer cells-Reference-Cited by-同舟云学术

Progesterone receptor membrane component 1 is phosphorylated upon progestin treatment in breast cancer cells

Published:2017-08-02 Issue:42 Volume:8 Page:72480-72493
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Willibald Marina¹,Bayer Giuliano¹,Stahlhut Vanessa¹,Poschmann Gereon²,Stühler Kai²³,Gierke Berthold⁴,Pawlak Michael⁴,Seeger Harald⁵,Mueck Alfred O.⁵,Niederacher Dieter¹,Fehm Tanja¹,Neubauer Hans¹

Affiliation:

1. Department of Obstetrics and Gynecology, University Hospital and Medical Faculty of the Heinrich-Heine University Duesseldorf, Duesseldorf, Germany

2. Molecular Proteomics Laboratory, BMFZ, Heinrich Heine University Duesseldorf, Duesseldorf, Germany

3. Institute for Molecular Medicine, University Hospital Duesseldorf, Duesseldorf, Germany

4. NMI Natural and Medical Sciences Institute at the University of Tuebingen, Reutlingen, Germany

5. Department of Women's Health, University Hospital and Faculty of Medicine of the Eberhard Karls University Tuebingen, Tuebingen, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PGRMC1 promotes triple-negative breast cancer cell growth via suppressing ferroptosis;Climacteric;2023-02-01

2. Clinical importance of PGRMC1 in hormone responsive breast cancer;Breast Care;2022-11-08

3. Pleiotropic Actions of PGRMC Proteins in Cancer;Endocrinology;2022-05-20

4. E2 + norethisterone promotes the PI3K–AKT pathway via PGRMC1 to induce breast cancer cell proliferation;Climacteric;2022-02-09

5. Progesterone Receptor Membrane Component 1 and Its Accomplice: Emerging Therapeutic Targets in Lung Cancer;Endocrine, Metabolic & Immune Disorders - Drug Targets;2021-11-30